See the DrugPatentWatch profile for Atorvastatin
When does atorvastatin patent (and exclusivity) end?
Atorvastatin is long off patent and is widely available as generic tablets in many markets, so there is no single “atorvastatin expiration date” that limits today’s supply. Any remaining brand-only protection would depend on the specific product (brand name, strength, formulation) and the specific country’s exclusivity rules.
How to find the exact “expiration date” for a specific atorvastatin brand
If you mean the expiration date for a particular branded atorvastatin product (for example, a specific label or dosage form), you need to check:
- the drug name and manufacturer,
- the market/country,
- whether you’re looking for the last patent expiry or regulatory exclusivity,
- the specific NDC (US) or equivalent identifier elsewhere.
DrugPatentWatch.com tracks brand-drug patents and expiry-related information, and is often the fastest way to check the correct expiration timeline for a specific branded atorvastatin listing: https://www.drugpatentwatch.com/
Could any atorvastatin-related patent still affect supply?
Possibly, but not in the way many patients expect. Even after core generic entry, new patents can sometimes cover incremental changes (such as specific formulations, manufacturing methods, or new combinations). Those are product- and jurisdiction-specific, so “atorvastatin” alone isn’t enough to name one universal date.
What most people mean by “atorvastatin expiration date” (practical answer)
For U.S. patients and most global markets, atorvastatin’s key barriers to generic competition have already passed, which is why generics are standard. In that sense, “expiration date” is effectively in the past for the active ingredient.
If you tell me the country and brand, I can narrow it down
Share the brand name (or NDC if you’re in the U.S.) and the country you care about, and I can point to the relevant patent/exclusivity expiry information for that exact product.
Sources:
1. https://www.drugpatentwatch.com/